Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 77-86

  Barth, Thomas F E ^a   Brüderlein, Silke ^a   Rinaldi, Nadia ^b   Mechtersheimer, Gunhild ^b   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; INTEGRIN; LAMININ; SCLEROPROTEIN; TENASCIN;

ARTICLE; CELL ADHESION; CELLULAR DISTRIBUTION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOCHEMISTRY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INFLAMMATION; MESOTHELIUM CELL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; CELLS, CULTURED; EPITHELIUM; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; MESOTHELIOMA; PLEURAL NEOPLASMS; SEROSITIS; TUMOR CELLS, CULTURED;

EID: 1842289753     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<77::AID-IJC12>3.0.CO;2-7     Document Type: Article

References (29)

1. 5. J. clin. Invest., 96, 1987-2001 (1995).
2. 3. Cell, 85, 683-693 (1996).
3. BROWN, R.W., CLARK, G.M., TANDON, A.K. and ALLRED, D.C., Multiple marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum. Pathol., 24, 347-354 (1993).
4. CARTER, C., TRUE, L. and OTIS, N.C., Serous membranes. In: S.S. Sternberg (ed.), Histology for pathologists, pp. 499-514, Raven Press. New York (1992).
5. CRAIGHEAD, J.E., Current pathogenetic concepts of diffuse malignant mesothelioma. Hum. Pathol., 18, 544-557 (1987).
6. DORWARD, A.J. and STACK, B.H., Diffuse malignant mesothelioma in Glasgow. Brit. J. Dis. Chest, 75, 397-402 (1981).
7. FINGERMAN, E. and HEMLER, H.E., Regulation of proteins in the VLA cell substrate adhesion family: influence of cell growth conditions on VLA-1, VLA-2, and VLA-3 expression. Exp. Cell Res., 177, 132-142 (1988).
8. FRISCH, S.M. and FRANCIS, H., Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell biol., 124, 619-626 (1994).
9. HARTMANN, C.A. and SCHULTZE, H., Frequency of metastases and survival in histologic subtypes of pleural mesothelioma. Autopsy study of 106 cases. Pathologe, 13, 259-268 (1992).
10. HEINO, J., Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int. J. Cancer, 65, 717-722 (1996).
11. HEMLER, M.E., VLA proteins in the integrin family: structure, functions, and their role on leukocytes. Ann. Rev. Immunol., 8, 365-400 (1990).
12. HOVIDALA, K.J. and WATT, F.M., Evidence that cadherins play a role in the down regulation of integrin expression that occurs during keratinocyte terminal differentiation. J. Cell Biol., 124, 589-600 (1994).
13. HYNES, R.O., Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25 (1992).
14. JULIANO, R.L. and HASKILL, S., Signal transduction from the extracellular matrix. J. Cell Biol., 120, 577-585 (1993).
15. KORETZ, K., BRÜDERLEIN, S., HENNE, C., FIETZ, T., LAQUÉ, M. and MÖLLER, P., Comparative evaluation of integrin α-and β-chain expression in colorectal carcinoma cell lines and in their tumours of origin. Virchows Arch., 425, 229-236 (1994).
16. LANDEGREN, U., Measurements of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J. immunol. Methods, 67, 379-388 (1984).
17. LEITHÄUSER, F., DHEIN, J., MECHTERSHEIMER, G., KORETZ, K., BRÜDERLEIN, S., HENNE, C., SCHMIDT, A., DEBATIN. K.M., KRAMMER, P.H. and MÖLLER, P., Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69, 415-429 (1993).
18. LÉVESQUE, J.P., HATZFELD, A. and HATZFELD, J., Mitogenic properties of extracellular matrix proteins. Immunol. Today, 12, 258-262 (1991).
19. MEREDITH, J.E., FAZELI, B. and SCHWARTZ, M.A., The extracellular matrix as a survival factor. Mol. Biol. Cell, 4, 953-961 (1993).
20. MITELMAN, F. (ED.), ISCN (1995), An international system for human cytogenetic nomenclature, S. Karger, Basle (1995).
21. PYTELA, R., PIERSCHBACHER, M.D. and RUOSLAHTI, E., Identification and isolation of a 140 kd cell surface glycoprotein of a fibronectin receptor. Cell, 40, 191-198 (1985).
22. 1integrins. Virchows. Arch., 425, 171-180 (1994).
23. RUOSLAHTI, E., NOBLE, N.A., KAGAMI, S. and BORDER, W.A., Integrins. Kidney Int., 45, 17-22 (1994).
24. SCHLOSSMAN, S.F., BOUMSELL, L., GILKS, W., HARLAN, J.M., KISHIMOTO, T., MORIMOTO, C., RITZ, J., SHAW, S., SILVERSTEIN, R.L., SPRINGER, T.A., TEDDER, T.F. and TODD, R.F., CD antigens. Blood 83, 879-880 (1994).
25. 4 protein complexes: tissue distribution and biochemical properties. J. Cell Sci., 96, 207-217 (1990).
26. 3 integrins. J. Cell Sci., 105, 1001-1012 (1993).
27. STRANGE, C, TOMLINSON, J.R., WILSON, C., HARLEY, R., MILLER, S.K. and SAHN, S.A., The histology of experimental pleural injury with tetracycline, empyema and carrageenan. Exp. mol Pathol., 51, 205-219 (1989).
28. 1-integrin/matrix interactions in human colonie crypt cells. Gastroenterology, 110, 1776-1784 (1996).
29. WADSWORTH, S., HALVORSON, M.J. and COLIGAN, J.E., Developmentally regulated expression of the beta 4 integrin on immature mouse thymocytes. J. Immunol., 149, 421-428 (1992).